US Patent 9545434 Treatment of short bowel syndrome patients with colon-in-continuity
Patent 9545434 was granted and assigned to Nps Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9545434 Treatment of short bowel syndrome patients with colon-in-continuity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
